doi: 10.1016/S0014-5793(00)02197-9 105 Du PlessisSSAgarwalAHalabiJTvrdaE
Were dedicated to helping you achieve better healthsafely and effectively
References (1) Biehl, Jesse K, and Brenda Russell
Furthermore, PD presents many challenges to therapeutic approaches, including the difficulty of introducing therapeutics into the brain, target specificity, potential inflammatory responses, safety concerns, tolerability for geriatric patients, ethical implications, and the mechanistic heterogeneity of the disease, refer to these reviews by Jarrin et al
Additionally, when many patients dropped out of the trials because the GLP-1 receptor agonists didnt work or the side effects were too bad, that data should have been counted
What are the basic tests recommended including Clinical laboratory IVD tests and related reasons to monitor GPL-1 RAs